Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a significant global health challenge, with conventional treatment methods often causing severe side effects due to non-specific targeting of healthy cells. The development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to improve treatment outcomes and reduce adverse effects. This thesis focuses on the design, development, and evaluation of advanced drug delivery systems tailored for targeted cancer therapy. The research encompasses a comprehensive review of the current literature on drug delivery systems and their applications in oncology, followed by a detailed investigation into the formulation and characterization of novel targeted delivery systems. Various methods, including nanoparticles, liposomes, and micelles, will be explored for their potential in enhancing drug efficacy and reducing toxicity. The introduction section provides a background to the study, highlighting the challenges in current cancer treatment approaches and the need for targeted drug delivery systems. The problem statement underscores the limitations of conventional therapies and the potential benefits of targeted drug delivery in improving patient outcomes. The objectives of the study are outlined, focusing on the development and evaluation of novel drug delivery systems for targeted cancer therapy. The limitations and scope of the study are also discussed, along with the significance of the research in advancing the field of oncology. The literature review chapter critically evaluates existing drug delivery systems used in cancer therapy, highlighting their strengths and limitations. Emphasis is placed on recent advancements in nanotechnology and biomaterials for enhancing drug delivery specificity and efficacy. The research methodology chapter details the experimental design, materials, and methods employed in formulating and evaluating the novel drug delivery systems. Key aspects such as synthesis, characterization, and in vitro/in vivo evaluation of the drug carriers will be thoroughly described. The discussion of findings chapter presents the results of the study, including the physicochemical characterization of the developed drug delivery systems and their efficacy in targeting cancer cells. The findings will be analyzed in the context of existing literature, providing insights into the potential clinical applications of the novel drug delivery systems. Lastly, the conclusion and summary chapter offer a comprehensive overview of the research outcomes, highlighting the key findings, implications, and future directions for advancing targeted cancer therapy through innovative drug delivery systems. In conclusion, the development and evaluation of novel drug delivery systems for targeted cancer therapy represent a promising avenue for improving treatment outcomes and patient quality of life. This thesis contributes to the growing body of knowledge in the field of oncology and drug delivery, offering insights into the potential of advanced drug carriers in revolutionizing cancer treatment strategies.